VialRetatrutide
Retatrutide (LY3437943)
Retatrutide is a triple-agonist peptide studied in metabolic research for combined GIP, GLP-1 and glucagon receptor activity.
Third-party tested · Purity 99% · For laboratory research use only.
- Purity
- 99%
- Form
- Powder (lyophilized)
- Available sizes
- 5mg, 10mg, 20mg, 30mg
Mechanism of Action
Research indicates simultaneous agonism of GIP, GLP-1 and glucagon receptors, influencing insulin secretion, satiety and energy expenditure.
Research Areas
- ●Metabolic and glycemic research
- ●Body composition studies
- ●Incretin pathway research